NBIO OTC
Nascent Biotech, Inc.
1W: +0.0%
1M: -33.3%
3M: -60.0%
YTD: -66.7%
1Y: -97.1%
3Y: -99.7%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$1M
+33.6% ▲
Capital Expenditures
$4
+0.0% ▲
Free Cash Flow
-$1M
+33.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$200K
+157.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$4M | -$959K | -$470K | -$3M | -$2M |
| Depreciation & Amort. | $0 | $0 | $0 | $1M | $0 |
| Stock-Based Comp. | $1M | $786K | $116K | $756K | $882K |
| Change in Working Capital | $2M | -$103K | $911K | -$317K | $164K |
| Other Non-Cash Items | $530K | -$711K | -$143K | -$1M | -$144K |
| Operating Cash Flow | -$554K | -$987K | $413K | -$2M | -$1M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | -$4 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $4 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $200K | $345K | -$320K | $2M | -$175K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $226K | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $426K | $985K | -$320K | $2M | $1M |
| Net Change in Cash | -$128K | -$2K | $93K | $78K | $200K |
| Cash End of Period | $3K | $1K | $94K | $172K | $372K |
| Free Cash Flow | -$554K | -$987K | $413K | -$2M | -$1M |